CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression
Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:
Efficacy of switching to 2-drug oral ART: real-world evidenceReal-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirinePatient selection to reduce risk of virologic failure with switch Regimen-specific switch considerationsPresenters:
The Role of Antimicrobial Stewardship Programs in Implementing Rapid Phenotypic AST
Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:
Considerations for implementationDecision-making steps for implementationThe role of antimicrobial stewardship programs in AST workflowPresenter:
Michael P. Veve, PharmD, MPH
Clinical Associate Professor
Department of Pharmacy Practice
Eugene Applebaum College of Pharmacy and Health Sciences
Wayne State University<...
Integration of Genotypic RDT With Rapid Phenotypic AST for Bloodstream Infections
Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:
Typical patterns of intrinsic antibiotic susceptibility and resistance in EnterobacteralesMechanisms of resistance in gram-negative bacteriaGenotypic rapid diagnostic tests for BSIsResistance markers for earlier targeted therapyRapid phenotypic antimicrobial susceptibility test platforms...The Ongoing Challenge of Antimicrobial Selection for Bloodstream Infections
Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:
The worldwide burden of sepsis and BSIsThe ongoing threat of antimicrobial resistanceUS and global health disparities in sepsis, BSI, and antimicrobial resistanceBarriers toward optimizing antibiotic use in BSIsPresenter:
Jasmine R. Marcelin, MD, FACP, FIDSA<...
Role of Pharmacists in PrEP Delivery
Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:
PrEP candidacy Selection of individualized regimensKey barriers to PrEP useStrategies for overcoming key barriers to PrEP accessEvolving state-based legislation on PrEP provision by pharmacistsModels of pharmacy-managed PrEPStrategies for addressing inequities in PrEP careComprehensive HIV prevention servicesPresenters:
Tessa Rife-Pennington, PharmD, BCGP
Dr. Dawn K. Smith HIV Prevention Clinical Fellow
American Ac...
Forging a Path Back to HIV Care
In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include:
How to approach a patient with complex barriers to engagement in healthcareResources for staying in care, such as wraparound servicesSetting SMART goals and formulating action plans with patientsDeconstructing stigma and implementing a trauma-informed approach to carePresenters:
Shellye Jones, MSW, LCSW
Clinical Supervisor
Charles R. Drew University, Drew CARES
Los Angeles, California
Overcoming Reluctance to Change as a Barrier to Optimizing ART for People Living With HIV and Viral Suppression
Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include:
International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral SuppressionConsiderations for switching to a 2-drug regimen or long-acting ARTMethods for assessing patient satisfaction with their current ART regimenPresenters:
Monica Gandhi, MD, MPH
Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Gl...
HIV “Blips”: What They Are (and Aren’t)
Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure, and how he handles each scenario.
Presenter:
Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington
Link to full program:
https://bit.ly/4nS7rYE
Get access to all of our new po...
Individualizing Care for Treatment-Experienced People With HIV
Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual’s specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include:
Individualizing Antiretroviral Regimens for Treatment-Experienced People With HIVStrategies to Improve Adherence and Addressing Barriers to Engagement in CarePerson-Centered, Trauma-Informed CareResistance Testing in the Setting of Virologic FailureSelection of ARVs With a Failing RegimenPresenters:
Clíona Ní Cheallaigh, MB, MRCP, PhD
Consultant Physician
Inclusion Health Services
St Jam...
Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections
In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:
Management for suspected drug-resistant CMV infection Illustrative patient cases Gene mutations in CMV
Presenters:
Atul Humar, MD, FRCPC, FAST
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
Cami...
Soundings Podcast: Identifying Refractory CMV Infections in Transplant Settings
Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:
Direct and indirect effects of CMV infectionRisk factors for resistant/refractory CMVDefining resistant/refractory CMVPresenter:
Camille Kotton, MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts
Link to full program:
http://bit.ly/4lOa2kA
Charting the Course Podcast: Antivirals for Refractory CMV Infections
Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:
Comparisons of available CMV antiviral therapies:Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavirConsiderations for renal function monitoring with ganciclovir and valganciclovirA treatment algorithm for relapsed/refractory CMVThe latest clinical trial data and guideline recommendationsPresenter:
Atul Humar, MD, FRCP (C)
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
L...
The Patient Angle: Individualized Approaches for Managing CMV
Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include:
Risk factors and prevention of late-onset CMV diseaseEarly detection of late CMV infectionCMV cell-mediated immunity monitoringPrimary and secondary prophylaxis
Presenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
The Viral Angle: CMV in Kidney Transplantation
Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include:
CMV pathogenesisDirect and indirect effects of CMV infection Overview of patient risk factorsCMV risk based on serologic status
Presenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Raymund R. Razonable, MD, FIDSA, FAST
Professor of Medicine
Division of Infectiou...
Syndromic Testing Podcast: Gastrointestinal and Joint Infections
Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.
Topics covered include:
Who should be tested for infectious diarrheaTypes of gastrointestinal syndromic panelsTypes of syndromic panels for joint infectionsReal-world applications for joint syndromic panelsPresenters:
Trevor Van Schooneveld, MD
Professor, Division of Infectious Diseases
Medical Director, Antimicrobial Stewardship Program
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Link to full program:
The Antiviral Angle: Leveraging the Full CMV Armamentarium
Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include:
Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methodsCharacteristics of available antiviral drugsMonitoring considerations for antiviralsPresenters:
Marcus Pereira, MD, MPH, FAST
Associate Professor of Medicine
Director of Clinical Services, Division of Infectious Diseases
Medical Director, Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York
Link to full program:
http://bit.ly/41ejruC...
Heartbreak to Hope: My Journey With Meningitis Vaccine Advocacy
Join Alicia Stillman of the American Society for Meningitis Prevention, as she shares a very personal story of loss that might change how you view meningitis vaccination.
Presenter:
Alicia Stillman, MBA, MPH
Patient Advocate
Co-Executive Director, American Society for Meningitis Prevention
Executive Director, Emily Stillman Foundation
Detroit, Michigan
Link to full program:
https://bit.ly/4mYvTXQ
Register for the practical symposium:
https://bit.ly/4mUOsvV
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple...
Syndromic Testing Podcast: Respiratory Infections
Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.
Topics covered include:
Types of upper and lower respiratory infection panelsConsiderations for when to use respiratory syndromic testingHow to use syndromic testing to guide both therapy escalation and de-escalationHow syndromic testing fits in with traditional testing methods, such as culture, antimicrobial susceptibility testing, Gram stain, and BAL cell countPresenter:
Michael Satlin, MD, MS, FIDSA
Associate Professor of Medicine and Pathology and L...
Advancing HIV Treatment: Leveraging Pharmacists’ Expertise
Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include:
Leveraging pharmacists’ expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:
Alexis E. Horace, PharmD, BCACP
Professor of Pharmacy Practice
University of Louisiana at Monroe College of Ph...
Lenacapavir Approval: What to Know When Selecting a PrEP Regimen
Tune in to learn how the recent FDA approval of lenacapavir (LEN) for PreP integrates into the current field of HIV prevention. Listen on the go or follow along with our expert-curated slides. Topics covered include:
The current landscape of PrEPFDA approval of lenacapavirPhase III efficacy and safety data for lenacapavirRecommendations and perspectives on the future of PrEPPresenters:
Colleen F. Kelley, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Co-Director, Emory Center for
AIDS Research
Associated Dean for Research,
Emory at Grady
Emo...
Key HIV Studies Influencing My Practice Following IAS 2025—Dr Beatriz Grinsztejn and Rosie Mngqibisa
Hear from experts in HIV care Beatriz Grinsztejn, MD, PhD, and Rosie Mnggibisa, MBChB, MPH, as they discuss their insights on some of the most clinically relevant new data presented at IAS 2025, including studies on:
Gaps in care for adolescents and young adults living with HIVGlobal impact of funding cutsAntiretroviral therapy for treating HIVPatient management strategies for people living with HIV and obesityPresenters:
Beatriz Grinsztejn, MD, PhD
Director
STI/HIV Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases – FIOCRUZ
Rio de Janeiro, Brazil
Rosie Mngqibisa, MBChB, MPH...
Syndromic Testing Podcast: Bloodstream Infections
Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.
Topics covered include:
The importance of good blood culture practices and finding the balance between overuse and underuseBlood culture improvement programsThe utility of rapid diagnostic testsResistance markers for earlier targeted therapyPresenters:
Emily Heil, PharmD, MS, BCIDP, AAHIVP
Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, Maryland
Link to full program:
Fundamentals on Integrating Specialized Agents for Treatment-Experienced People With HIV
Tune in as Dr George Behrenspresents the fundamentals on specialized agents for treatment-experienced people living with HIV.
Topics covered include:
Key targets and mechanisms of action for specialized HIV drugsClinical trial data supporting safety and efficacy of these agentsConsiderations for potential drug–drug interactions Strategies for leveraging these agents to construct new ART regimens for treatment-experienced individualsPresenters:
Georg Behrens, MD
Professor of Immunology
Senior Consultant
Department of Rheumatology and Immunology
Hannover Medical School, Germany
Hannover, Germany
Link to full program:
https://bit.ly/4oiYxEx
G...
Essentials for ART Selection for Treatment-Experienced People With HIV and Comorbidities
In this episode, Dr Josep M. Llibrereviews the essentials on ART selection for treatment-experienced people with HIV and comorbidities.
Topics covered include:
Underlying reasons for development of multidrug-resistant HIVInflammation and immune activation associated with frequency of age-related conditions General principles for designing ART regimens for persons with multidrug-resistant HIVTreatment options for highly treatment‒experienced peopleConsiderations for comorbidities and drug–drug interactionsPresenters:
Josep M. Llibre, MD, PhD
Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain
Link to full program:
ht...
Key Principles for Getting Started With Managing Multidrug-Resistant HIV
Tune in as Dr Daniel R. Kuritzkes presents a quick and easy primer on managing multidrug resistant HIV.
Topics covered include:
How to recognize key populations who may present with multidrug-resistant HIVIdentifying underlying reasons for regimen failureEvaluating resistance profilesConstructing new ART regimens for treatment-experienced individuals.Presenters:
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Link to full program:
https://bit.ly/4oiYxEx
Get access to all of ou...
Key PBC Studies From EASL and DDW 2025
In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:
Steatotic liver disease and PBCVibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBCPPAR agonists and IBATs for PBC treatment
Presenter:
Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United...
Expert Insights for Transforming Your Practice Into a Vaccine Center of Excellence
Listen as expert faculty answer your most pressing questions on optimizing immunization in clinical practice.
Topics covered include:
Practical methods for improving confidence in vaccinesHow to educate patients on vaccine development and safety monitoring Effective strategies to tailor recommendations, such as motivational interviewingWays to navigate clinical encounters and address vaccine hesitancyPresenters:
Robert H. Hopkins, Jr., MD, MACP
Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical Sciences
College of Medicine
Little Rock, Arkansas
Litjen (L.J.) Tan, MS, PhD
Chief Policy and Partnership Office, I...
Partnering With Patients for PBC Care: Actionable Strategies for HCPs
In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including:
Disease concerns and frequently asked questions from a patient perspectiveManaging symptomsTreatment options and supportive careImportance of awareness and educationPresenters:
Gideon Hirschfield, MA, MB BChir, FRCP, PhD
Lily and Terry Horner Chair in Autoimmune Liver Disease Research
Professor, Division of Gastroenterology and Hepatology
University of Toronto
Director, The Autoimmune and Rare Liver Disease...
PBC Perspectives: A Patient and HCP in Conversation
In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss:
The chronic nature of PBCGoing beyond biochemical markers to assess and address symptoms such as fatigue and pruritusThe importance of referral to patient support groupsPresenters:
Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Director, General Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York
Maria G. Morais, RN
VP...
Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast
In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include:
How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelparPotential outcomes if ALP normalization cannot be achievedThe importance of managing fatigue, pruritus, and sleep disturbances independently of the biochemical responsePresenters:
Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Managing PBC Therapy for Patients With Cirrhosis: Curbside Consults Podcast
In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients with cirrhosis. Topics covered include:
AASLD guideline recommendations for second-line therapy for PBCConsiderations when using newer agents for second-line treatment of PBC in patients with cirrhosis: elafibranor and seladelparPresenters:
Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan
Nancy Reau, MD
Professor of Medicine
...
Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics
In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:
The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresenters
Brett M. Elicker, MD
Professor of Clinical Radiology
Chief, Cardiothoracic Imaging Division
Department of Radiology & Biomedical Imaging
University of California, San Francisco
San Fr...
Evaluating and Managing PBC Symptoms: Curbside Consults Podcast
In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include:
Strategies and tools for assessing pruritusNonpharmacologic and pharmacologic management of pruritusSecond-line agents and their impact on pruritusInvestigational treatments for pruritusPresenters:
Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
Aparna Goel...
Defining Nonresponse to PBC Treatment: Curbside Consults Podcast
How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including:
How and when to measure treatment responseEvidence-based goals of therapyConsiderations for second-line treatmentNew agents for second-line treatment: PPAR agonistsPresenters:
Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts
Aparna Goel, MD
...
Listen Up: Time to Prioritize RSV Vaccination for Adults
Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions.
In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.
Listen as they discuss:
The Burden of Adult RSVRSV Vaccines for Adults: Data and RecommendationsRSV Vaccine UptakePractical Strategies to Increase RSV Vaccine UptakeFaculty:
Dr. Ruth Carrico is a family nurse pr...
Paving the Way: Overcoming Barriers to RSV Vaccination
Listen in as Carolyn Bridges, MD, FACP, and Laura P. Hurley, MD, MPH, discuss barriers to respiratory syncytial virus (RSV) vaccination for adults, including insurance coverage and vaccine hesitancy, and explore effective, practical strategies for overcoming these barriers. Topics covered include:
Helping patients understand why they need an RSV vaccineWays to discuss real-world vaccine efficacyApproaches to build vaccine confidence and discuss vaccine safetyMethods to overcome financial barriers and time constraintsVaccine delivery infrastructurePresenters:
Carolyn Bridges, MD, FACP
Consulting Physician and Director of Adult Immunizations
Immunize.org
St Paul, Minnesota
Laura...
The Latest Data and Guidelines for Adult RSV Vaccines
Listen in as Carolyn Bridges, MD, FACP, reviews the estimated burden of respiratory syncytial virus (RSV) disease in older adults and discusses the latest updates on RSV vaccination recommendations and safety data. Topics covered include:
Rates of RSV hospitalizations and emergency department visitsRSV vaccine developmentFDA-approved RSV vaccinesVaccine safety data: rates of atrial fibrillation and Guillain-Barré syndromeACIP RSV vaccine recommendationsRisk factors for severe RSV diseaseRSV vaccine uptakePresenter:
Carolyn Bridges, MD, FACP
Consulting Physician and Director of Adult Immunizations
Immunize.org
St Paul, Minnesota
Link to full program:
https://bit.ly/4mH...
Overcoming Common Hurdles to RSV Vaccination in Post-acute and Long-term Care
In this episode, Jewel Mullen, MD, MPH, MPA, and Dallas Nelson, MD, CMD, FACP discuss overcoming barriers to RSV vaccine uptake in post-acute and long-term care facilities, including:
How to incorporate the latest RSV vaccination recommendations into clinical practicePractical strategies for navigating insuranceEffective and empathetic methods of addressing vaccine hesitancy.
Presenters:
Jewel Mullen, MD, MPH, MPA
Associate Dean for Health Equity
Associate Professor of Population Health and Internal Medicine
University of Texas at Austin Dell Medical School
Austin, Texas
Dallas Nelson, MD, CMD, FACP
Professor of Medic...
Key HIV Studies Influencing My Practice Following CROI 2025—Dr Chloe Orkin and Dr Jean-Michel Molina
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, discuss highlights from CCO’s independent conference coverage of CROI 2025, including:
Advances in HIV treatment based on results from CARESPotential HIV therapies in the pipeline, such as doravirine/islatravirEffects of broadly neutralizing antibodies on HIV treatment and cure Key clinical data on HIV and STI prevention obtained from PILLAR, HPTN 083, PURPOSE 1, and STOMPPresenters:
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Honorary Consultant Physician, Barts Health NHS Trust
Faculty of Medicine and Den...
COVID-19 in EU: Inpatient Treatment Options for Severe COVID-19 in People Who Are Immunocompromised
Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including:
Antiviral therapy with remdesivirDexamethasone for patients with hematologic malignanciesConsiderations regarding other immunomodulators such as JAK inhibitors or IL-6 inhibitorsA detailed patient case to illustrate key takeaways
Presenters:
Michele Bartoletti, MD, PhD
Associate Professor of Infectious Diseases
Department of Biomedical Sciences
Humanitas University
Pieve Emanuele (MI), Italy
Head of Infectious Diseases Unit
IRCCS Humanitas Research Hospital
Rozzano (MI...
